These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11207049)

  • 1. The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications.
    Ria F; Landriscina M; Remiddi F; Rosselli R; Iacoangeli M; Scerrati M; Pani G; Borrello S; Galeotti T
    Br J Cancer; 2001 Feb; 84(4):529-34. PubMed ID: 11207049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma.
    Park CK; Jung JH; Moon MJ; Kim YY; Kim JH; Park SH; Kim CY; Paek SH; Kim DG; Jung HW; Cho BK
    Oncology; 2009; 77(3-4):178-81. PubMed ID: 19641337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
    Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
    Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.
    Asgari S; Röhrborn HJ; Engelhorn T; Stolke D
    Acta Neurochir (Wien); 2003 Jun; 145(6):453-59; discussion 459-60. PubMed ID: 12836069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.
    Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D
    Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glioblastomas: clinical study and search for prognostic factors].
    Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
    Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese superoxide dismutase expression in human central nervous system tumors.
    Cobbs CS; Levi DS; Aldape K; Israel MA
    Cancer Res; 1996 Jul; 56(14):3192-5. PubMed ID: 8764104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
    Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
    Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
    Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
    Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
    Hermann B; Li Y; Ray MB; Wo JM; Martin RC
    Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
    Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer.
    Janssen AM; Bosman CB; van Duijn W; Oostendorp-van de Ruit MM; Kubben FJ; Griffioen G; Lamers CB; van Krieken JH; van de Velde CJ; Verspaget HW
    Clin Cancer Res; 2000 Aug; 6(8):3183-92. PubMed ID: 10955802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma.
    Hidaka T; Hama S; Shrestha P; Saito T; Kajiwara Y; Yamasaki F; Sugiyama K; Kurisu K
    Anticancer Res; 2009 Feb; 29(2):597-603. PubMed ID: 19331209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.